HIV Infection: Drugs

(asked on 18th June 2019) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to his speech of 30 January 2019 to the AIDS free cities global forum, what recent assessment he has made of the adequacy of funding available to local authorities in London to enable the doubling of places on the PrEP Impact Trial.


Answered by
Seema Kennedy Portrait
Seema Kennedy
This question was answered on 26th June 2019

HIV pre-exposure prophylaxis (PrEP) is currently available through the three year, NHS England funded PrEP impact trial, which is providing HIV prevention drugs to people at high risk of HIV infection. Expansion of the trial is underway across the country following my Rt hon. Friend the Secretary of State for Health and Social Care’s announcement in January that the trial would be expanded to 26,000 people. In London, boroughs have agreed to provide over 4,000 extra places on the trial, which represents a 60% increase in the number of trial places. Participation in the trial is on a voluntary basis and it is for clinics and local authorities to decide whether they wish to take part.

Reticulating Splines